AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimijen M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Jemon Pharmaceutical

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimijen M 1mg/500mg Tablet

Diabetic patients using the dual-action formulation, Glimepiride/Metformin 1mg/500mg tablets, benefit from its blood glucose-regulating properties. This antidiabetic medication, a combination therapy for adult-onset type 2 diabetes, effectively manages blood sugar. Consistent daily dosing, ideally with meals, is crucial for optimal efficacy. Dosage adjustments are determined by your physician based on your blood glucose monitoring. Discontinuing treatment without medical supervision risks elevated blood sugar and potential complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. A comprehensive diabetes management plan, incorporating a balanced diet, regular exercise, and weight management as recommended by your doctor, is essential. Hypoglycemia (low blood sugar) is a common adverse effect, manifested by symptoms such as sweating, dizziness, headaches, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is necessary. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating therapy. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Primary Ingredients of Glimijen M 1mg/500mg Tablet

No text provided to rephrase.

Uses of Glimijen M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimijen M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimijen M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Glimijen M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimijen M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimijen M 1mg/500mg Tablet whole; do not crush, chew, or break it. Administer this medicine with food.

How Glimijen M 1mg/500mg Tablet works:

Glimijen M 1mg/500mg tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimijen M 1mg/500mg tablets with alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimijen M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimijen M 1mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimijen M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimijen M 1mg/500mg tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

For individuals with liver impairment, the use of Glimijen M 1mg/500mg tablets requires careful monitoring. Dosage modification of Glimijen M 1mg/500mg tablets may be necessary. Medical advice is recommended. In patients experiencing mild to moderate liver disease, Glimijen M 1mg/500mg tablets are typically initiated at a low dosage; however, their use is contraindicated in those with severe liver dysfunction.

What if you forget to take Glimijen M 1mg/500mg Tablet :

Should you forget a Glimijen M 1mg/500mg Tablet dose, administer it immediately if feasible. Conversely, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimijen M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimijen M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimijen M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these symptoms, discontinue Glimijen M 1mg/500mg Tablets and seek immediate medical attention.
Glimijen M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimijen M 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Glimijen M 1mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimijen M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimijen M 1mg/500mg tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Glimijen M 1mg/500mg Tabl...
27
MRP 33
18% off